Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis
WEDNESDAY, July 8, 2020 -- Upadacitinib monotherapy results in improved outcomes versus methotrexate for patients with predominantly early rheumatoid arthritis, according to a study published online July 8 in Arthritis & Rheumatology.
Ronald van...
Read more »